Pharmacotherapeutic management of erectile dysfunction

Clinical Pharmacology and Therapeutics
D J Hawksworth, A L Burnett

Abstract

Erectile dysfunction is a common condition in aging men and significantly affects their quality of life and interpersonal relationships. Its prevalence and incidence are associated with aging, lifestyle factors and cardiovascular comorbidities. Preoccupation with male virility has been present for centuries, and a wide variety of herbs and potions have been used to treat any sexual deficiencies. Recent major advances in understanding of erectile physiology and pathophysiology led to development of currently available systemic and local pharmacotherapies. They are designed to work either centrally or peripherally and to either suppress anti-erectile mechanisms, enhance the pro-erectile ones or influence both. Since all the current formulations have variable safety and efficacy profiles, the search for highly specific, simple, convenient and clinically effective impotence treatments or prophylactics continues.

References

May 16, 1975·Brain Research·A BjörklundA Nobin
Jun 12, 1992·Annals of the New York Academy of Sciences·A Argiolas
Jan 1, 1992·Neuron·D S Bredt, S H Snyder
Jul 17, 1992·Science·A L BurnettS H Snyder
Jan 1, 1992·Experimental Brain Research·L Marson, K E McKenna
Mar 1, 1990·Pharmacology, Biochemistry, and Behavior·A ArgiolasG L Gessa
Oct 1, 1989·The Journal of Urology·I Saenz de TejadaI Goldstein
Jan 1, 1987·Neuroscience and Biobehavioral Reviews·D Bitran, E M Hull
Jan 1, 1987·European Journal of Clinical Pharmacology·J A OwenA Morales
Jan 1, 1987·The Journal of Clinical Endocrinology and Metabolism·M S CarmichaelJ M Davidson
Apr 1, 1981·Journal of Endocrinological Investigation·A Bertolini, G L Gessa
Mar 1, 1994·Neuroscience·S SaitoD F Hanley
Jan 1, 1995·The Journal of Urology·A L BurnettD F Hanley
Jan 1, 1995·Physiological Reviews·K E Andersson, G Wagner
Jun 1, 1993·The Journal of Urology·A C Campos de CarvalhoD C Spray
Jan 1, 1993·Fundamental & Clinical Pharmacology·A J Lees
Jul 7, 1993·JAMA : the Journal of the American Medical Association
Oct 7, 1997·International Journal of Impotence Research·W MeinhardtJ Zwartendijk
Jan 13, 1999·International Journal of Impotence Research·A TraishI Goldstein
May 20, 1999·Annual Review of Pharmacology and Toxicology·D R Sibley
Jun 13, 2000·International Journal of Impotence Research·F Giuliano, O Rampin
Jun 13, 2000·International Journal of Impotence Research·I Goldstein
Oct 18, 2000·International Journal of Impotence Research·H WessellsV Hruby
Apr 6, 2001·World Journal of Urology·I GoldsteinA Islam
Mar 16, 2002·International Journal of Impotence Research·A T GuayM E Geisser

❮ Previous
Next ❯

Citations

Jan 16, 2016·Clinical Pharmacology and Therapeutics·M F Paine, B P Smith
May 4, 2017·Expert Opinion on Investigational Drugs·Li Smith-HarrisonJason R Kovac
Aug 19, 2017·International Journal of Molecular Sciences·Jeffrey D Campbell, Arthur L Burnett
Aug 16, 2016·F1000Research·Chintan K Patel, Nelson Bennett
Nov 13, 2020·International Journal of Clinical Pharmacy·Luis Fernando Valladales-Restrepo, Jorge Enrique Machado-Alba
Oct 6, 2020·Aging and Disease·Zhonglin CaiHongjun Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.